Salt-Sensitivity and Immunity Cell Activation

Clinical trial NCT03753204 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03753204
Sponsor: Vanderbilt University Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

High Blood Pressure Salt; Excess Inflammation

Start date: 2021-09-01
Primary completion: 2026-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.